Candriam S.C.A. Sutro Biopharma, Inc. Transaction History

Candriam S.C.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$3.27 - $5.65 $1.5 Million - $2.59 Million	-457,812 Reduced 50.97%	440,422 $2.49 Million
Q4 2023 Feb 14, 2024	SELL	$2.07 - $4.54 $1.32 Million - $2.91 Million	-640,000 Reduced 41.61%	898,234 $3.85 Million
Q3 2023 Nov 13, 2023	SELL	$3.29 - $4.9 $296,100 - $441,000	-90,000 Reduced 5.53%	1,538,234 $5.34 Million
Q2 2023 Aug 08, 2023	SELL	$4.25 - $5.88 $988,299 - $1.37 Million	-232,541 Reduced 12.5%	1,628,234 $7.57 Million
Q1 2023 May 12, 2023	BUY	$4.48 - $8.45 $4.8 Million - $9.05 Million	1,071,591 Added 135.78%	1,860,775 $8.6 Million
Q4 2022 Feb 13, 2023	SELL	$5.41 - $8.08 $5.46 Million - $8.16 Million	-1,009,654 Reduced 56.13%	789,184 $6.38 Million
Q3 2022 Nov 10, 2022	BUY	$5.17 - $7.11 $8.98 Million - $12.3 Million	1,736,225 Added 2772.95%	1,798,838 $9.98 Million
Q2 2022 Aug 03, 2022	BUY	$3.41 - $8.95 $213,510 - $560,386	62,613 New	62,613 $326,000
Q3 2021 Nov 09, 2021	SELL	$16.88 - $22.38 $6.18 Million - $8.2 Million	-366,207 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$18.03 - $23.82 $34,311 - $45,329	-1,903 Reduced 0.52%	366,207 $6.81 Million
Q1 2021 Apr 29, 2021	SELL	$20.29 - $27.54 $81 - $110	-4 Reduced -0.0%	368,110 $7.68 Million
Q4 2020 Jan 22, 2021	BUY	$10.16 - $23.98 $3.74 Million - $8.83 Million	368,114 New	368,114 $7.99 Million

140

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $98.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.